Business Standard

Top headlines: Pfizer's pill cuts risk of severe Covid; Delhi AQI worsens

Business Standard brings you the top headlines on Friday

A man rides a bicycle in front of the historic Red Fort, shrouded in smog post Diwali celebrations in New Delhi (Photo: PTI)
Premium

A man rides a bicycle in front of the historic Red Fort, shrouded in smog post Diwali celebrations in New Delhi (Photo: PTI)

BS Web Team New Delhi
Pfizer develops Covid pill that cuts hospitalisations and deaths by 89%

Pfizer Inc. said its Covid-19 pill reduced hospitalisations and deaths in high-risk patients by 89%, a result that has the potential to upend how the disease caused by the coronavirus is treated and alter the course of the pandemic.

The drugmaker said in a statement on Friday that it was no longer taking new patients in a clinical trial of the treatment “due to the overwhelming efficacy” and planned to submit the findings to U.S. regulatory authorities for emergency authorization as soon as possible. Read more

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in